Feb 19,2021

Digital Health Technology Catalyst

MyWay Digital Health and partners have been awarded funding from Innovate UK, for a £1million project to develop an artificial intelligence system to support decision making for clinicians and people with diabetes.

FUNDING GRANT
View Analyst & Ambassador Comments
Go to original news
Dec 18,2017

Bigfoot Biomedical's automated insulin delivery systems attract $37M in Series B funding

Milpitas, California-based diabetes management device maker Bigfoot Biomedical has raised $37 million in Series B funding in a round co-led by funds from Janus Henderson Investors and Quadrant Capital Advisors. Additional participants included Cormorant Asset Management, Senvest Capital Inc., Senvest Management LLC, Visionnaire Ventures, JDRF T1D Fund, and T1D Exchange.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Dec 20,2017

Biotech startup Nuritas raises €16 million in Series A funding

Nuritas, an Irish biotech startup, has raised €16 million in a Series A round led by US firm Cultivian Sandbox Ventures. Nuritas has built a medical platform that uses artificial intelligence to analyse peptides in food that can positively impact in conditions like pre-diabetes while reducing the cost and time needed to find them.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Dec 05,2017

Health2Sync lands $6 million in Series B funding for Japanese expansion

Diabetes management company Health2Sync is looking to expand its operation into Japan after raising $6 million in Series B investments led by Sompo Holdings, one of Japan’s largest insurance companies.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jan 04,2016

Robert Bosch Venture Capital leads $3.1M round in digital diabetes startup

Germany-based digital health startup Emperra has raised $3.1 million in a round led by Robert Bosch Venture Capital with participation from existing investors, Peppermint VenturePartners and Investitionsbank des Landes Brandenburg. Emperra offers a digital diabetes management system that includes connected health devices and software. The company's executives also contributed to the round. Emperra's primary product, Esysta, includes smart insulin pens, wireless-enabled blood glucose meters, and CE-marked software that runs on various platforms including smart TVs, web portals, and mobile apps.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Apr 12,2016

Livongo Health raises $44.5M for its cellular-enabled diabetes management system

Mountain View, California-based Livongo Health, the diabetes management company launched two years ago by former Allscripts CEO Glen Tullman, has raised $44.5 million from Merck Global Health Innovation Fund, Cowen Private Investments, Sapphire Ventures, Zaffre Investments, the investment arm of Blue Cross Blue Shield of Massachusetts, and Wanxiang America Corporation. This brings the company’s total funding to at least $79.5 million.

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Apr 07,2016

OurCrowd & Philips Join to Raise $3.5 Million for Sweetch MedTech Startup

Sweetch Health, an Israeli medtech startup that has developed a “digital vaccine” for diabetes, has received series A funding in the amount of $3.5 million. The funding round was led by global conglomerate Philips and leading equity crowdfunding platform OurCrowd. The funding also saw participation from earlier investors including Lionbird and Pontifax. Sweetch’s behavioral analytics engine may also be applied to other significant chronic diseases and pre-chronic disease states, such as pre-hypertension and hypertension, obesity and metabolic syndrome.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
May 10,2016

Humana makes strategic investment in connected diabetes management company Livongo

Livongo, the mobile-enabled diabetes management company, has raised a strategic investment from Humana to support the company’s growth. Update: Humana invested $5 million in Livongo.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Jun 17,2016

Solera Health raises another $4M for its diabetes prevention programs marketplace

Phoenix, Arizona-based Solera Health added another $4 million in funding from investors to help connect providers, payers and patients with diabetes prevention programs available in their area. The company announced $3 million in funding last November. Return backers BlueCross BlueShield Venture Partners and Sandbox Ventures participated in the new injection of funds as did new investor, social impact fund, SJF Ventures.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Jul 25,2016

DreaMed raises $3.3M for its diabetes management clinical decision support software

Israel-based DreaMed Diabetes announced this week that it has raised $3.3 million from Norma Investments, Russian businessman Roman Abramovich and one other unnamed angel.

FUNDING VENTURE ROUND
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING